Low-Dose Imaging Effective for Ruling Out CAD

Article

HealthDay News - Coronary computed tomography may provide alternative to catheter-based angiography

HealthDay News - Low-dose coronary computed tomography (CT) appears as sensitive as catheter-based angiography and may provide a non-invasive alternative to the latter for ruling out coronary artery disease (CAD) in symptomatic patients, according to a meta-analysis published in the March 15 issue of the Annals of Internal Medicine.

Moritz Wyler von Ballmoos, MD, PhD, MPH, of the Harvard School of Public Health in Boston, and colleagues analyzed 16 studies comprising 960 patients to summarize current evidence on the ability of low-dose coronary CT for ruling out CAD in symptomatic adults.

The researchers determined the sensitivity and specificity of the technique to be 1.00 and 0.89, respectively, at the patient level. The pooled vessel- and segment-level estimates had lower sensitivity and higher specificity than did the patient-level estimates. The researchers found statistically significant heterogeneity between studies for vessel- and segment-level estimates, and this seemed to be related to body mass index and prevalence of CAD, though not with CT scanner characteristics. The researchers concluded that evidence suggests low-dose coronary CT angiography matches catheter-based angiography's sensitivity with low radiation exposure and may be a valid alternative to catheter angiography for triaging symptomatic patients with a suspicion of CAD.

"This noninvasive technique is associated with a low effective radiation dose of 2.7 mSv. However, our meta-analysis is based on a small number of studies, many of which were done at a single academic site and presumably with the same expert operators. Further studies are therefore needed before widespread diffusion of the technology can be recommended," the authors write.

AbstractFull Text (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.